Listen Aphasia Pilot Study

This is a feasibility and pilot study to refine and test LISTEN, an AI-based augmentative and alternative communication (AAC) smartphone app, integrated into the patient's personal electronic device, to augment and facilitate communication in patients with tumor-related aphasia (TRA) and their care partners. The study will assess the feasibility and acceptability of LISTEN in patients with TRA and their care partners.

NCT Number	NCT07732140
Lead Sponsor	Dana-Farber Cancer Institute
Conditions	Aphasia, Malignant Brain Tumor
Enrollment	80 participants
Start Date	2027-01
Primary Completion	2030-05 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2026-07-28